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Background: Accurate and simple prognostic criteria based on histopathology following pancreati-
coduodenectomy would be helpful in assessing prognosis and considering and evaluating adjuvant
therapy. This study analysed the histological parameters influencing outcome following pancreati-
coduodenectomy for periampullary malignancy.
Methods: A total of 110 pancreaticoduodenectomies were performed from 1998 to 2008. The median
age of patients was 69 years (range 20–89 years). The median follow-up was 4.9 years. Of the procedures,
87% (96) were performed for malignancies and the remainder (n = 14) for benign aetiologies. Of the 96
malignancies, 60 were pancreatic adenocarcinoma and the rest were ampullary (14), cholangio (9),
duodenal (9) carcinomas and others. Statistical analysis was performed using log-rank and Cox regres-
sion multivariate analyses.
Results: Patients who underwent resection had 1-, 3- and 5-year survival rates of 70%, 46% and 41%,
respectively. The 1-, 3- and 5-year survival rates for periampullary cancers other than pancreatic adeno-
carcinoma were 83%, 69% and 61%, respectively; those for pancreatic adenocarcinoma were 62%, 31%
and 27%, respectively (P < 0.003). Poor tumour differentiation (P < 0.02), tumour size >3 cm (P < 0.04),
margin 2 mm (P < 0.02), nodal involvement (P < 0.003), perineural infiltration (P < 0.0001) and lym-
phovascular invasion (P < 0.002) were associated with poorer prognosis. In a multivariate analysis,
histologically identified perineural infiltration (P < 0.03) and lymphovascular invasion (P = 0.05) were
significant factors influencing outcome. Five-year survival was 77% in patients negative for both factors
and 15% in patients positive for both (P < 0.0001). In the pancreatic adenocarcinoma subgroup, patients
who were negative for both factors had a 5-year survival of 71%, whereas those who were positive for
both had a 5-year survival of 16% (P < 0.02).
Conclusions: The presence of perineural infiltration and lymphovascular invasion on histopathology is
highly significant in predicting 5-year outcomes after pancreaticoduodenectomy for periampullary and
pancreatic malignancies.
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Introduction
Patient survival associated with malignancy in the region of the
pancreatic head remains poor compared with other abdominal
malignancies despite improvements in surgical technique and
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perioperative and in-hospital mortality. Factors influencing
longterm patient survival include tumour type, tumour
staging (tumour-node-metastasis [TNM] status), resectability,
co-morbidity and patient age. Despite the decrease in periope-
rative mortality from 30% in the early 1980s1 to 3% in the last
decade,2 5-year patient survival rates after curative resection
remain dismal. Most published large series quote post-resection
survival rates of only 4–17% for pancreatic adenocarcinoma.3–8
The picture is better for ampullary carcinoma, where 5-year
survival rises to 60% following resection.9
The traditional determinants of patient survival following
pancreaticoduodenectomy include tumour margin, tumour type,
tumour size, tumour differentiation and regional nodal status.
Two other parameters that have often been reported but not
analysed in detail are perineural tumour infiltration and lym-
phovascular invasion. A recent study from Groningen concluded
that perineural infiltration is highly significant in prognosticating
patient survival after pancreatic resection.10 Two studies have
reported decreased survival in neuroendocrine tumours of the
pancreas when lymphovascular invasion is present.11,12 It is pos-
tulated that perineural infiltration may be responsible for local
failure because of tumour growth along nerves which innervate
the pancreas and eventually form the periarterial neural plexus.13
Likewise, the presence of lymphovascular infiltration may be
responsible for regional or distant metastasis in lymph nodes or
other organs such as lungs or liver.
This study aimed to analyse the histopathological parameters
influencing longterm patient survival after pancreaticoduode-
nectomy focusing on perineural infiltration and lymphovascular
invasion as predictors of longterm survival.
(A) (B)
Figure 1 Haematoxylin and eosin sections showing (A) lymphovascular invasion of tumour in a lymphatic away from the main tumour and
(B) perineural infiltration (black arrow) by tumour along a bundle of nerves in the pancreas
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Figure 2 Cumulative patient survival following Whipple resection for malignancy (n = 96)
102 HPB
HPB 2010, 12, 101–108 © 2009 International Hepato-Pancreato-Biliary Association
Materials and methods
All patients who underwent pancreaticoduodenectomy at
Flinders Medical Centre and the hospitals of the Adelaide
Community Healthcare Alliance between June 1998 and June
2008 were included in the study. The histopathological parameters
analysed included tumour type, tumour size, tumour differentia-
tion, regional lymph node status, resection margin, perineural
infiltration and lymphovascular invasion. In reports with in-
complete information about the required histopathological
parameters, the histopathological slides (n = 18 patients) were
re-examined. Tumour types were divided into two groups of
malignancies: pancreatic adenocarcinoma and other periampul-
lary tumours. The ‘other periampullary’ group consisted of amp-
ullary carcinoma, duodenal carcinoma, cholangiocarcinoma and
neuroendocrine malignancies. Tumour size was categorized as
<2 cm, 2–3 cm and >3 cm. Tumour differentiation was classified
as good, moderate or poor. The resection margins were analysed
starting from involved margin (0 mm) using 1-mm increments
until statistical significance was reached. For the majority of
tumours resected before 2002, the margin referred to is that of
the pancreatic neck resection line as well as the portal vein margin.
After 2002, the surgical margin included all margins (i.e. anterior,
posterior, pancreatic neck and portal vein margins). A typical
specimen was inked and then fixed prior to sectioning for margin
analysis. Nodal involvement was categorized as positive or nega-
tive. There was no attempt to analyse the number of positive
nodes or the station involved. Lymphovascular invasion was posi-
tive if tumour was noted within the lymphovascular channels
(Fig. 1A). Perineural infiltration was considered to be present if
tumour cells were identified within the perineural space and/or
Table 1 Malignancies treated by Whipple resection (n = 96)
Pancreatic adenocarcinoma n = 60
Periampullary malignancies n = 36
Ampullary carcinoma n = 14
Cholangiocarcinoma n = 9
Duodenal carcinoma n = 9
Neuroendocrine malignancies n = 4
Table 2 Five-year survival rates in patients treated by resection for
periampullary malignancies and pancreatic adenocarcinoma, by age
and gender (n = 96)
n 1 year 3 years 5 years P-value
Overall 96 70 46 41
Sex
Female 44 78 48 43 0.32
Male 52 61 43 38
Age, years
<65 22 84 51 51 0.28
65–70 31 62 36 31
>70 43 69 50 42
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Figure 3 Cumulative survival in patients with periampullary malignancies (ampullary carcinoma, duodenal carcinoma, cholangiocarcinoma
and neuroendocrine malignancies) and patients with pancreatic adenocarcinoma. At a median follow-up of 4.9 years, the periampullary
group had a 5-year actuarial survival of 61%, which is significantly better than that achieved by patients with pancreatic adenocarcinoma
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nerve bundle (Fig. 1B). For the purposes of statistical analysis,
cases in which lymphovascular invasion was not seen on haema-
toxylin and eosin (H&E) stained sections but which showed
positive lymph nodes were included in the ‘negative for lym-
phovascular invasion’ group.
Data analysis
Univariate analysis was carried out using the log-rank test with
differences in patient survival as the outcome measure. Continu-
ous variables, such as age and tumour size, were converted into
categorical variables. Determinants that were significant on
univariate analysis were then subjected to multivariate analysis
using Cox multi-regression analysis. All statistical analyses were
carried out using spss Version 11.0.1 (SPSS, Inc., Chicago, IL,
USA).
Results
A total of 110 pancreaticoduodenectomies were performed in the
study institutions over the 10-year period. The median follow-up
was 4.9 years. The median patient age was 69 years (range 20–89
years). There were 58 men among the patients. There were four
(3.6%) in-hospital/30-day deaths. Fourteen resections were
performed for benign diseases which included intrapapillary
mucinous neoplasia (IPMNs), tubulovillous adenoma with
dysplasia, ganglioneuroma, impacted common bile duct stone
masquerading as a tumour, lymphoepithelial cyst and bleeding
following pancreatic trauma. These were not included in further
analysis. The remaining 96 patients had a resection for malig-
nancy. The majority were performed for pancreatic adenocar-
cinoma (n = 60; Table 1). The overall 5-year actuarial survival
for all patients with malignancy was 41% (Fig. 2). There was no
difference in 5-year survival in terms of age or gender (Table 2).
Patients who underwent resection for pancreatic adenocarcinoma
had poorer survival (27% at 5 years) than patients with other
periampullary malignancies (42% at 5 years; P < 0.002) (Fig. 3).
Tumour size, margin and differentiation and
nodal status
Smaller and well-differentiated tumours were associated with
significantly better patient survival (P < 0.03 and P < 0.01, res-
pectively) (Table 3). Positive lymph nodes were associated with
reduced survival (P < 0.003). Sequential margin analysis revealed
that the longterm survival difference became significant when
the margin was clear by 2 mm (P < 0.01). At a margin of 1 mm
there was no statistical difference in terms of longterm survival.
Well-differentiated tumours were associated with significantly
Table 3 Five-year survival rates by tumour characteristics (n = 96)
n 1 year 3 years 5 years P-value
Tumour
Periampullary 36 83 69 61 <0.002
Pancreatic adenocarcinoma 60 62 31 27
Tumour size
<2 cm 25 80 67 67 <0.03
2–3 cm 35 66 27 21
>3 cm 28 65 41 35
Margin
>2 mm 50 76 54 51 <0.01
2 mm 28 58 29 23
Differentiation
Good 12 83 73 73 <0.01
Moderate 47 73 51 44
Poor 33 57 23 19
Nodal metastases
No 56 76 54 51 <0.003
Yes 40 62 35 22
Lymphovascular invasion
No 61 75 60 51 <0.002
Yes 35 61 23 23
Perineural infiltration
No 45 84 72 69 <0.0001
Yes 51 58 21 14
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Figure 4 Cumulative patient survival in the presence of perineural infiltration along nerves within the pancreatic tissue. Perineural infiltration
is associated with a significantly poorer survival outcome
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Figure 5 Cumulative patient survival in the presence of tumour invasion in lymphovascular channels under microscopic examination.
Lymphovascular invasion is associated with a poorer survival outcome
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better longterm survival compared with moderately and poorly
differentiated tumours (P < 0.01).
Perineural infiltration and lymphovascular invasion
The absence of malignant perineural infiltration was associated
with highly significantly improved survival (Fig. 4). Similarly, the
absence of lymphovascular invasion was associated with improved
survival (Fig. 5).
Multivariate analysis
When all the significant histopathological parameters on univari-
ate analysis were assessed using a multivariate regression model,
perineural infiltration (P < 0.03) and lymphovascular invasion
(P = 0.05) were the only independent factors prognostic for long-
term survival.
Prognostic modelling using perineural infiltration and
lymphovascular invasion
As these two factors were independently significant in multivari-
ate analysis, the effects of combining them in terms of predicting
longterm survival were analysed. The 96 patients with malignan-
cies were divided into four categories consisting of those who
were positive for both parameters, those who were positive for
either one of the parameters and those who were negative for
both. Figure 6 illustrates that patients who were negative for both
parameters had significantly better survival than the other groups
(P < 0.0001). The 5-year actuarial survival is tabulated in Table 4.
Likewise, when these parameters were applied to patients with
pancreatic adenocarcinoma, those who were negative for both
parameters had an excellent actuarial 5-year survival of 71% com-
pared with the other three groups (Fig. 7, Table 5).
Discussion
Pancreatic malignancies overall are associated with poor longterm
prognosis. Five-year survival rates following pancreatic resection
for pancreatic adenocarcinoma remain low (<20%), even in large-
volume institutions. This cohort had a median follow-up of nearly
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Figure 6 Cumulative patient survival in the presence or absence of perineural infiltration and lymphovascular invasion after resection.
Survival is significantly improved if both features are absent on microscopic examination
Table 4 Five-year survival rates after pancreaticoduodenectomy
for pancreatic malignancies in patients positive and negative for
perineural infiltration and lymphovascular invasion (n = 96)
Perineural - Perineural +
Lymphovascular - 77% 14%
Lymphovascular + 42% 15%
Table 5 Five- year survival rates after pancreaticoduodenectomy for
pancreatic adenocarcinoma in patients positive and negative for
perineural infiltration and lymphovascular invasion (n = 60)
Perineural - Perineural +
Lymphovascular - 71% 22%
Lymphovascular + 0% 16%
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5 years and an actuarial survival of 27%, which is comparable with
the recently published MD Anderson series.14 The 5-year survival
for patients who underwent pancreaticoduodenectomy for peri-
ampullary malignancies other than pancreatic adenocarcinoma
was 61%. This result is also in line with previously published
results for periampullary carcinomas, including a recently pub-
lished series from Birmingham which reported an actuarial 5-year
survival of 60% for ampullary carcinoma following resection.9
An involved pancreatic resection margin is associated with
poor patient outcome.15 The European Study Group for Pancre-
atic Cancer (ESPAC) defines an R0 resection as having a margin
1 mm. In our series, a surgical margin of2 mm was associated
with better patient survival. A recent study reported a margin of
1.5 mm to be associated with better outcome.16 If this is borne
out by other investigators, a re-evaluation of the R0 margin will
be required.
The TNM classification and its modifications have been
the standard prognostic parameters used for most malignancies,
including those of pancreatic origin.17 The factors that were inde-
pendently significant on multivariate analysis in this cohort were
perineural infiltration and lymphovascular invasion, which are
not part of the TNM system. Perineural infiltration as a signifi-
cant prognostic factor after pancreatic head resection has been
reported previously and has been postulated to be related to local
failure by various authors.10,18 As the tumour grows along nerves
in the pancreas, it infiltrates distally and is more likely to follow
arterial channels, hence reducing the chances of achieving com-
plete microscopic clearance.10,13 Lymphovascular infiltration may
provide a conduit for metastasis as indicated by poorer outcome
despite aggressive vein resection, as reported in a larger cohort
of patients.13 Lymphovascular invasion has been previously noted
as a significant prognostic factor following resection of neuroen-
docrine tumours of the pancreas.11
When lymphovascular invasion and perineural infiltration
were absent, the 5-year actuarial survival was 77% in patients
undergoing Whipple resection for all malignancies (n = 96), and
71% in patients undergoing resection for pancreatic adenocarci-
noma (n = 60). It is apparent that these two parameters, which are
easily identified on H&E sections, are highly discriminating as
pathological prognostic criteria for predicting survival following
pancreatic resection for malignancies including pancreatic adeno-
carcinoma. These pathological prognostic criteria will have to be
tested in other pancreatic resection series. The findings in this
paper suggest that a neoadjuvant approach to pancreatic malig-
nancy may be beneficial. Unfortunately, there are no comparative
trials to ascertain the benefits of one approach over another. These
data add further support to the call for a direct comparison
of neoadjuvant vs. adjuvant treatment in resectable pancreatic
cancer.
Currently, perineural infiltration and lymphovascular invasion
are not part of the standard prognostic criteria after resection
of pancreatic or other periampullary cancers. These data would
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Figure 7 Cumulative patient survival in the presence of perineural infiltration and lymphovascular invasion after resection for pancreatic
adenocarcinoma. The group with the best prognosis in this cohort included those without identifiable perineural infiltration or lymphovascular
invasion
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strongly argue for the inclusion of these parameters in any post-
operative staging system. We propose that a new periampullary-
specific staging system is required for both research and clinical
purposes.
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